Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 12, 2004

 

 

TEMPUR-PEDIC INTERNATIONAL INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware   001-31922   33-1022198
(State or other jurisdiction
of incorporation or organization)
  (Commission File No.)   (I.R.S. Employer
Identification No.)
         
   

1713 Jaggie Fox Way

Lexington, Kentucky 40511

   
(Address of principal executive offices) (Zip Code)

(800) 878-8889

(Registrant’s telephone number, including area code)

 

 

 


Item    7. Financial Statements, Pro Forma Financial Information and Exhibits

 

(c) Exhibits

 

Exhibit

  

Description


99.1    Press Release dated July 12, 2004, titled “Tempur-Pedic International Inc. Reaffirms 2004 Guidance.”

 

 

Item    9. Regulation FD Disclosure

 

The information furnished under Item 12 of this Form 8-K, including Exhibit 99.1 furnished herewith, is hereby incorporated by reference under this Item 9 as if fully set forth herein.

 

 

Item    12. Results of Operations and Financial Condition

 

On July 12, 2004, Tempur-Pedic International Inc. issued a press release stating that it would be releasing its financial results for the second quarter ended June 30, 2004 on July 22, 2004, as previously announced, and reaffirming its guidance for the year ended December 31, 2004.

 

The information in this report shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 12, 2004

 

 

Tempur-Pedic International Inc.

By:

  

/S/    ROBERT B. TRUSSELL, JR.

    
    

Name:    Robert B. Trussell, Jr.

    

Title:      President and Chief Executive Officer

 


EXHIBIT INDEX

 

Exhibit

  

Description


99.1    Press Release dated July 12, 2004, titled “Tempur-Pedic International Inc. Reaffirms 2004 Guidance.”
Press Release

Exhibit 99.1

 

 

TEMPUR-PEDIC INTERNATIONAL INC. REAFFIRMS 2004 GUIDANCE

 

For Immediate Release

 

LEXINGTON, KENTUCKY, July 12, 2004 — Tempur-Pedic International Inc. (NYSE: TPX) announced today that it was reaffirming its guidance for the full year 2004.

 

The Company reaffirmed that it expects net sales for 2004 will be between $620 million and $640 million, and its pro forma fully diluted net income per share for 2004 will be between $0.70 and $0.73. The Company notes that its expectations are based on information available at the time of this release, and are subject to changing conditions, many of which are outside the Company’s control. For supplemental information about the adjustments included in the pro forma net income information, please refer to the Company’s April 22, 2004 earnings release for the first quarter.

 

 

Conference Call

 

As previously announced, Tempur-Pedic International will release its earnings after the market closes on July 22, 2004 and will host a conference call to discuss second quarter results at 5 p.m. Eastern Time (2 p.m. Pacific Time). The telephone number for the call is (800) 795-1259. The live conference call, featuring President and Chief Executive Officer Robert Trussell and Chief Financial Officer Dale Williams, will be recorded and can be reviewed until July 29, 2004 by calling (888) 562-3381.

 

The online replay will be available for 30 days on the Tempur-Pedic International investor relations website at http://www.tempurpedic.com/ir.

 

 

Forward-Looking Statements

 

This release contains “forward-looking statements,” which include information concerning the Company’s plans, objectives, goals, strategies, future revenues and performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements, including, without limitation, management’s expectations regarding its net sales and pro forma net income for 2004, are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct.

 

There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the Company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the Company’s Annual Report on Form 10-K under the headings “Special Note Regarding Forward Looking Statements” and “Business-Risk Factors” filed with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

 

 

About the Company

 

Tempur-Pedic International Inc. (NYSE: TPX) manufactures and distributes Swedish Sleep System® mattresses and neck pillows made from the revolutionary Tempur® pressure-relieving material, a visco-elastic material that conforms to the body to provide support and help alleviate pressure points. Products are currently sold in 54 countries under the Tempur® and Tempur-Pedic® brand names. World headquarters for Tempur-Pedic International are in Lexington, KY. For more information about the Company, visit http://www.tempurpedic.com or call 800-878-8889.

 

Source: Tempur-Pedic International Inc.